Recent studies suggest that CD169+ macrophages in tumor regional lymph nodes are positively associated with favorable prognosis in patients with colorectal cancer, bladder cancer, endometrial carcinoma, or malignant melanoma (65–68). The gene discussed is SIGLEC1; the disease is endometrial carcinoma.